TENX
NASDAQ
US
Tenax Therapeutics, Inc. - Common Stock
$15.02
▼ $-0.99
(-6.16%)
Vol 335K
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$76.1M
ROE
-43.2%
Margin
-10115.8%
D/E
0.00
Beta
1.48
52W
$5–$14
Wall Street Consensus
12 analysts · Apr 20265
Strong Buy
6
Buy
1
Hold
0
Sell
0
Strong Sell
91.7%
Buy Rating
Price Chart
Similar Stocks
EDIT
Editas Medicine Inc
$200.1M
TLSI
TriSalus Life Sciences Inc
$348.8M
CHRS
Coherus Oncology Inc
P/E 1.1
$171.6M
ALXO
ALX Oncology Holdings Inc
$61.3M
IKT
Inhibikase Therapeutics Inc
$248.6M
KROS
Keros Therapeutics Inc
P/E 9.6
$620.3M
VYGR
Voyager Therapeutics Inc
$218.5M
RNA
Atrium Therapeutics Inc
$10.9B
ELDN
Eledon Pharmaceuticals Inc
$113.4M
Earnings
Beat rate: 25.0%
Next Report
May 12, 2026
EPS Estimate: $-0.41
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.41 | — | — |
| Dec 2025 | $-0.42 | $-0.38 | +$0.04 |
| Sep 2025 | $-0.32 | $-0.40 | $-0.08 |
| Jun 2025 | $-0.24 | $-0.27 | $-0.03 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -31.3% | -31.3% | -31.3% | -31.3% | -43.2% | -43.2% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -10115.8% | -10115.8% | -10115.8% | -10115.8% | -10115.8% |
| Gross Margin | — | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 41.89 | 41.89 | 41.89 | 41.89 | 15.58 | 15.58 |
Key Ratios
ROA (TTM)
-41.5%
P/S (TTM)
1543.80
P/B
0.2
EPS (TTM)
$-1.13
CF/Share
$-0.49
52W High
$14.22
52W Low
$4.63
$4.63
52-Week Range
$14.22
How does TENX compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
TENX valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
1543.8
▲
11914%
above
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
0.2
▼
91%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
TENX profitability vs Biotechnology peers
ROE
-43.2%
▲
36%
above
peers
(-67.3%)
vs Peers
vs Industry
Below avg
Net margin
-10115.8%
▼
3428%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
100.0%
▲
27%
above
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
-41.5%
▲
11%
above
peers
(-46.7%)
vs Peers
vs Industry
In line
TENX financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
15.6
▲
251%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.5
▲
53%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
TENX fundamentals radar
TENX
Peer median
Industry
TENX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
TENX vs peers: key metrics
Latest News
No related news yet